InteRNA Technologies: InteRNA Appoints Established Oncology Innovator Andrea van Elsas, PhD, to its Supervisory Board
InteRNA Technologies, a clinical-stage biotech company developing microRNA (miRNA)-based therapeutics with a focus on cancer, announced today the appointment of Andrea van Elsas, PhD, as a new member
Source: finanznachrichten.de